Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes : Episode 6
Engaging Primary Care Clinicians in Screening for Hypercortisolism
Medical experts explore why findings from this study are crucial for clinicians managing diabetes, particularly those in primary care settings, and how these insights can impact their approach to patient care.
EP: 1.Overview of the CATALYST Study for Hypercortisolism
EP: 2.Defining Difficult to Control Diabetes
EP: 3.CATALYST Trial Study Design
EP: 4.True Prevalence of Hypercortisolism
EP: 5.Coexisting Cardiometabolic Conditions and Hypercortisolism
Now Viewing
EP: 6.Engaging Primary Care Clinicians in Screening for Hypercortisolism
EP: 7.Spectrum of Hypercortisolism Presentations
EP: 8.Mifeprestone for Treatment of Hypercortisolism
EP: 9.Reconsidering Standard of Care for Hypercortisolism
Video content above is prompted by the following:
Why should clinicians who manage patients with diabetes, the majority of whom are in the primary care setting, care about the findings from this study?
Recent Videos
